trending Market Intelligence /marketintelligence/en/news-insights/trending/3wep5ObfxLwwMgNabIVVJg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Oncolix appoints board member

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Oncolix appoints board member

Oncolix Inc. appointed John Holaday as an independent board member.

Holaday's appointment makes him one of two independent directors, fulfilling an OTC-QB listing requirement.

Holaday is the co-founder, and most recently CEO, managing director and board member of QRxPharma Ltd.